Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study

Published 2016 View Full Article

Authors

Keywords

Chronic hepatitis B, Entry inhibitor, Hepatitis B virus receptor, Hepatitis B treatment, Hepatitis D, Hepatitis D treatment, Myrcludex B, Sodium taurocholate co-transporting polypeptide (NTCP, SLC10A1), Virus kinetic modeling

Journal

JOURNAL OF HEPATOLOGY

Volume 65, Issue 3, Pages 490-498

Publisher

Elsevier BV

Online

2016-04-30

DOI

10.1016/j.jhep.2016.04.016

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started